Meet the team

Contact details:

01223 639507

Secretary

Louise Downes
Tel: 01223 639777
Email: louisedownes@nhs.net

Specialties: 

Respiratory Medicine (adults) General Internal Medicine (adults)

Dr Baxendale joined the Clinical Immunology Department at Royal Papworth Hospital NHS Foundation Trust in February 2011. She is based in the Centre for Lung Infection (incorporating The Adult Cystic Fibrosis Centre, The Lung Defence Clinic and The Immunology Clinic) where she provides the clinical immunology service for investigation and management of patients with recurrent lung infection and immunodeficiency. She also holds an Honorary Consultant contract at Addenbrooke’s Hospital where she provides the Paediatric Immunology service and works closely with clinicians providing the adult immunology service. Dr Baxendale holds an Honorary academic position at the University of Cambridge.

Previously she worked as a Senior Lecturer in Clinical Immunology at University College London (UCL) and prior to this was a Clinician Scientist at the UCL Institute of Child Health.

R. Andres Floto is a Wellcome Trust Investigator and Professor of Respiratory Biology in the Molecular Immunity Unit of the University of Cambridge (based at the MRC Laboratory of Molecular Biology), Research Director of the Cambridge Centre for Lung Infection at Royal Papworth Hospital, and Director of the UK Cystic Fibrosis (CF) Innovation Hub. 

His basic research is focused on understanding how macrophages interact with bacteria, how bacteria evolve during chronic infection and transmission, and how forward and reverse genetics can be combined with fragment-based drug discovery to develop novel antibiotics and host-directed therapies.

His clinical research is centred around tackling chronic inflammation in CF and non-CF bronchiectasis, treating Nontuberculous Mycobacteria (NTM), and using graphical model-based machine learning to understand and predict pulmonary exacerbations in CF. 

Clinically he specialises in the management of Nontuberculous mycobacteria, Cystic Fibrosis, non-CF bronchiectasis, and recurrent chest infections
He co-chairs the British Thoracic Society NTM guidelines committee, the joint US CF Foundation-European CF Society (ECFS) NTM Guidelines Group, and the ECFS working group on NTM.
 

Charles Haworth is Director of the Cambridge Centre for Lung Infection (incorporating The Adult Cystic Fibrosis Centre, The Lung Defence Clinic and The Respiratory Immunology Clinic) at Royal Papworth Hospital. He is also an Honorary Consultant at Addenbrooke’s Hospital in Cambridge.

The Adult Cystic Fibrosis Centre oversees the care of >330 adults with CF. The Lung Defence Clinic oversees the care of >2000 patients with bronchiectasis associated with primary and secondary immunodeficiencies, non-tuberculous mycobacterial (NTM) lung disease, Aspergillus related lung disease, rheumatoid arthritis, serious childhood infection, chronic aspiration and primary ciliary dyskinesia. 

Both the Adult Cystic Fibrosis Centre and Lung Defence Clinic have European Reference Network (ERN) designation.

Charles Haworth trained at the Manchester Adult Cystic Fibrosis Centre, Hammersmith Hospital and the Royal Brompton Hospital before moving to Cambridge in 2003. 

Dr Haworth is the senior author of the US Cystic Fibrosis Foundation & European Cystic Fibrosis Society NTM guidelines published in 2016 and first author of the British Thoracic Society NTM guidelines published in 2017. He also co-authored the European Respiratory Society Bronchiectasis guidelines published in September 2017 and is a member of the British Thoracic Society Bronchiectasis guidelines committee. 

Dr Haworth is an Honorary Visiting Senior Fellow in the Department of Medicine at the University of Cambridge; he is a member of two European Union Framework Programme 7 funded  research consortia (iABC and CFMATTERS); he is co-chief investigator of three current international multicentre novel therapy clinical trials in people with bronchiectasis; he is the Papworth site Principal Investigator for the European Cystic Fibrosis Society Clinical Trials network; he is a member of the US Cystic Fibrosis Foundation Data Safety Monitoring Board; he is a Steering Committee and Scientific Committee member of the European Bronchiectasis Registry (EMBARC); he is a member of the Cystic Fibrosis Trust Strategic Implementation Board; and a member of the European Cystic Fibrosis Society Scientific Committee.

Dr Uta Hill is a respiratory consultant in the Cambridge Centre for Lung Infection contributing to the Cystic Fibrosis service and the Lung Defence and Immunology services.

Her areas of expertise include cystic fibrosis medicine, aspergillus-related lung disease, non-tuberculous mycobacterial infection, primary ciliary dyskinesia, chronic pseudomonal infection and medical education.

She is the Deputy Foundation Training Programme Director at Royal Papworth Hospital.

Chris Johnson is Clinical Lead for the Lung Defence and Immunology Services at Royal Papworth Hospital and Consultant to the Adult Cystic Fibrosis Unit. He is also an Honorary Consultant at Addenbrooke’s Hospital in Cambridge and a Board Member of the European Reference Network on Rare Lung disease.

The Lung Defence Clinic oversees the care of >2000 patients with bronchiectasis associated with primary and secondary immunodeficiencies, chronic Pseudomonal infection, non-tuberculous mycobacterial (NTM) lung disease, Aspergillus related lung disease, rheumatoid arthritis, serious childhood infection, chronic aspiration and primary ciliary dyskinesia.

Chris trained at the Universities of Cambridge and Oxford before completing his post-graduate training in Cambridge and undertaking a Preceptorship at Royal Papworth Hospital, the University of North Carolina at Chapel Hill and the National Jewish Hospital in Denver, USA.

He is also the Trust’s Chief Medical Information Officer with responsibility for clinical IT systems and has various national roles in IT with NHS Digital.
 

Dr Nicky Simler is the Clinical Lead for the Cambridge Interstitial Lung Disease Unit. She graduated from Manchester Medical School in 1993. Dr Simler completed an MD Thesis whilst working in the Interstitial Lung Disease service at Wythenshawe Hospital investigating the role of pro-angiogenic cytokines in interstitial pneumonia.

She completed her higher respiratory training in North West Thames with experience in the Royal Brompton Interstitial Lung Disease service before taking up her consultant role in Hinchingbrooke and Royal Papworth Hospitals in 2006.

Dr Simler has an interest in Clinical Trials and is currently the Respiratory Specialty Lead for the Eastern Clinical Research Network.  She is also the Training Programme Director for Respiratory Medicine in the East of England.